Dyadic International Inc (DYAI)
1.19
+0.07
(+6.25%)
USD |
NASDAQ |
Nov 14, 12:55
Dyadic International Profit Margin (Quarterly): -530.0% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -530.0% |
March 31, 2024 | -600.6% |
December 31, 2023 | -301.8% |
September 30, 2023 | -406.6% |
June 30, 2023 | -257.2% |
March 31, 2023 | -97.79% |
December 31, 2022 | -288.6% |
September 30, 2022 | -205.7% |
June 30, 2022 | -499.3% |
March 31, 2022 | -384.3% |
December 31, 2021 | -1.35K% |
September 30, 2021 | -247.5% |
June 30, 2021 | -410.4% |
March 31, 2021 | -715.5% |
December 31, 2020 | -566.7% |
September 30, 2020 | -600.3% |
June 30, 2020 | -505.7% |
March 31, 2020 | -702.1% |
December 31, 2019 | -401.4% |
September 30, 2019 | -373.7% |
June 30, 2019 | -689.7% |
March 31, 2019 | -540.4% |
December 31, 2018 | -74.59% |
September 30, 2018 | -585.4% |
June 30, 2018 | -989.9% |
Date | Value |
---|---|
March 31, 2018 | -1.11K% |
December 31, 2017 | -871.3% |
September 30, 2017 | -555.9% |
June 30, 2017 | -650.7% |
March 31, 2017 | |
December 31, 2016 | -420.0% |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | -1.08K% |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | -1.64K% |
March 31, 2015 | -997.8% |
December 31, 2014 | -1.50K% |
September 30, 2014 | |
March 31, 2014 | -52.56% |
December 31, 2013 | -13.34% |
September 30, 2013 | -50.32% |
June 30, 2013 | 46.92% |
March 31, 2013 | -58.84% |
September 30, 2012 | -15.54% |
June 30, 2012 | 50.59% |
March 31, 2012 | -30.95% |
December 31, 2006 | -94.14% |
September 30, 2006 | -55.75% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.35K%
Minimum
Dec 2021
-97.79%
Maximum
Mar 2023
-477.2%
Average
-410.4%
Median
Jun 2021
Profit Margin (Quarterly) Benchmarks
AIM ImmunoTech Inc | -3.67K% |
Perspective Therapeutics Inc | -- |
Protalix BioTherapeutics Inc | -16.35% |
Electromed Inc | 12.32% |
Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -128.2% |
Return on Assets | -74.63% |
Return on Invested Capital | -93.31% |
Gross Profit Margin (Quarterly) | 21.75% |
Operating Margin (Quarterly) | -528.5% |
Return on Net Operating Assets | -720.2% |